# Efficacy and Safety of 3 Different Dosage Regimens of Hyaluronic Acid in Patients With Knee Osteoarthritis (OA)

> **NCT01290497** · PHASE4 · COMPLETED · sponsor: **Tedec-Meiji Farma, S.A.** · enrollment: 45 (actual)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **DRUG:** Hyaluronic acid 5 x 2.5 ml
- **DRUG:** Hyaluronic acid 1 x 5 ml
- **DRUG:** Hyaluronic acid 2 x 5 ml

## Key facts

- **NCT ID:** NCT01290497
- **Lead sponsor:** Tedec-Meiji Farma, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-10
- **Final completion:** 2011-11
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2014-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01290497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01290497, "Efficacy and Safety of 3 Different Dosage Regimens of Hyaluronic Acid in Patients With Knee Osteoarthritis (OA)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01290497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*